PROK Insider Trading

Insider Ownership Percentage: 41.49%
Insider Buying (Last 12 Months): $74,919,037.82
Insider Selling (Last 12 Months): $23,681,744.10

ProKidney Insider Trading History Chart

This chart shows the insider buying and selling history at ProKidney by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

ProKidney Share Price & Price History

Current Price: $2.11
Price Change: Price Decrease of -0.08 (-3.65%)
As of 07/19/2024 01:00 AM ET

This chart shows the closing price history over time for PROK up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

ProKidney Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/13/2024Pablo G LegorretaDirectorBuy22,617,909$2.42$54,735,339.7822,617,909View SEC Filing Icon  
6/11/2024Control Empresarial De CapitalInsiderBuy8,264,462$2.42$19,999,998.0471,560,107View SEC Filing Icon  
5/20/2024Darin J WeberInsiderSell17,238$4.08$70,331.04137,956View SEC Filing Icon  
4/22/2024Darin J WeberSVPSell16,438$2.51$41,259.38155,194View SEC Filing Icon  
4/18/2024Darin J WeberSVPSell800$2.54$2,032.00171,632View SEC Filing Icon  
4/16/2024Darin J WeberSVPSell17,238$2.50$43,095.00172,432View SEC Filing Icon  
4/12/2024Darin J WeberSVPSell84,103$1.73$145,498.19189,670View SEC Filing Icon  
4/1/2024Darin J WeberSVPSell300$1.69$507.00273,773View SEC Filing Icon  
3/25/2024Control Empresarial De CapitalInsiderBuy30,000$1.43$42,900.0063,295,645View SEC Filing Icon  
3/22/2024Control Empresarial De CapitalInsiderBuy14,000$1.40$19,600.0063,265,645View SEC Filing Icon  
3/20/2024Control Empresarial De CapitalInsiderBuy33,000$1.40$46,200.0063,251,645View SEC Filing Icon  
3/13/2024Control Empresarial De CapitalInsiderBuy50,000$1.50$75,000.0063,168,645View SEC Filing Icon  
11/19/2023Chamath PalihapitiyaMajor ShareholderSell7,256,367$1.31$9,505,840.77View SEC Filing Icon  
11/17/2023Chamath PalihapitiyaMajor ShareholderSell258,400$1.19$307,496.005,183,367View SEC Filing Icon  
11/15/2023Chamath PalihapitiyaMajor ShareholderSell282,300$1.49$420,627.005,653,867View SEC Filing Icon  
11/13/2023Chamath PalihapitiyaMajor ShareholderSell88,700$1.57$139,259.006,242,367View SEC Filing Icon  
11/10/2023Chamath PalihapitiyaMajor ShareholderSell85,900$1.61$138,299.006,331,067View SEC Filing Icon  
11/8/2023Chamath PalihapitiyaMajor ShareholderSell59,000$1.66$97,940.006,512,867View SEC Filing Icon  
11/6/2023Chamath PalihapitiyaMajor ShareholderSell79,600$1.56$124,176.006,643,100View SEC Filing Icon  
11/3/2023Chamath PalihapitiyaMajor ShareholderSell148,300$1.73$256,559.006,722,700View SEC Filing Icon  
11/1/2023Chamath PalihapitiyaMajor ShareholderSell123,400$1.62$199,908.007,004,700View SEC Filing Icon  
10/30/2023Chamath PalihapitiyaMajor ShareholderSell157,000$1.65$259,050.007,270,000View SEC Filing Icon  
10/27/2023Chamath PalihapitiyaMajor ShareholderSell92,500$1.59$147,075.007,427,000View SEC Filing Icon  
10/25/2023Chamath PalihapitiyaMajor ShareholderSell67,213$1.76$118,294.887,597,460View SEC Filing Icon  
10/23/2023Chamath PalihapitiyaMajor ShareholderSell160,300$1.83$293,349.007,840,973View SEC Filing Icon  
10/20/2023Chamath PalihapitiyaMajor ShareholderSell87,200$1.92$167,424.008,001,273View SEC Filing Icon  
10/18/2023Chamath PalihapitiyaMajor ShareholderSell125,100$2.28$285,228.008,288,473View SEC Filing Icon  
10/16/2023Chamath PalihapitiyaMajor ShareholderSell215,543$2.87$618,608.418,519,973View SEC Filing Icon  
10/12/2023Chamath PalihapitiyaMajor ShareholderSell161,863$2.69$435,411.478,985,516View SEC Filing Icon  
10/9/2023Chamath PalihapitiyaMajor ShareholderSell75,000$4.20$315,000.009,297,379View SEC Filing Icon  
10/5/2023Chamath PalihapitiyaMajor ShareholderSell52,621$4.76$250,475.969,447,379View SEC Filing Icon  
9/19/2023Chamath PalihapitiyaMajor ShareholderSell1,700,000$5.47$9,299,000.002,073,000View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for ProKidney (NASDAQ:PROK)

51.59% of ProKidney stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at PROK by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

ProKidney Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/10/2024Vanguard Group Inc.1,813,079$2.97M0.0%-37.5%0.791%Search for SEC Filing on Google Icon
4/24/2024Zullo Investment Group Inc.19,420$32K0.0%N/A0.008%Search for SEC Filing on Google Icon
2/7/2024Jump Financial LLC21,677$39K0.0%-54.0%0.009%Search for SEC Filing on Google Icon
1/31/2024Federated Hermes Inc.113,286$0.20M0.0%+10,984.7%0.048%Search for SEC Filing on Google Icon
1/12/2024SG Americas Securities LLC46,829$83K0.0%+174.2%0.020%Search for SEC Filing on Google Icon
11/7/2023New York State Common Retirement Fund17,274$79K0.0%-30.1%0.007%Search for SEC Filing on Google Icon
11/7/2023Jump Financial LLC47,100$0.22M0.0%N/A0.020%Search for SEC Filing on Google Icon
10/27/2023Social Capital Group LLC11,573,000$53M89.0%-12.8%4.922%Search for SEC Filing on Google Icon
10/24/2023Bank of New York Mellon Corp127,956$0.59M0.0%-21.9%0.054%Search for SEC Filing on Google Icon
10/13/2023SG Americas Securities LLC17,080$78K0.0%N/A0.007%Search for SEC Filing on Google Icon
8/10/2023Letko Brosseau & Associates Inc.15,900$0.18M0.0%N/A0.007%Search for SEC Filing on Google Icon
8/10/2023Metropolitan Life Insurance Co NY3,429$38K0.0%N/A0.001%Search for SEC Filing on Google Icon
8/4/2023American International Group Inc.29,698$0.33M0.0%N/A0.013%Search for SEC Filing on Google Icon
8/3/2023Bank of New York Mellon Corp163,811$1.83M0.0%N/A0.070%Search for SEC Filing on Google Icon
7/31/2023Strs Ohio12,800$0.14M0.0%N/A0.005%Search for SEC Filing on Google Icon
7/19/2023Salem Investment Counselors Inc.3,000$34K0.0%+547.9%0.001%Search for SEC Filing on Google Icon
2/13/2023Social Capital Group LLC13,273,000$91.05M77.7%N/A51.767%Search for SEC Filing on Google Icon
2/8/2023Swiss National Bank74,301$0.51M0.0%N/A0.290%Search for SEC Filing on Google Icon
1/24/2023Brown University1,000,000$6.86M2.9%N/A3.900%Search for SEC Filing on Google Icon
11/15/2022Bleichroeder LP2,000,000$18.02M3.8%N/A7.800%Search for SEC Filing on Google Icon
11/14/2022Verition Fund Management LLC14,603$0.13M0.0%N/A0.057%Search for SEC Filing on Google Icon
11/14/2022Moore Capital Management LP26,500$0.24M0.0%N/A0.103%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
ProKidney logo
ProKidney Corp., a clinical-stage biotechnology company, provides transformative proprietary cell therapy platform for treating various chronic kidney diseases in the United States. The company's lead product is Renal Autologous Cell Therapy (REACT), an autologous homologous cell admixture, which has completed Phase I clinical trial for REACT in patients with congenital anomalies of the Kidney and Urinary Tract (CAKUT), as well as in Phase III and Phase II clinical trials for the treatment of moderate to severe diabetic kidney disease. ProKidney Corp. founded in 2015 and is headquartered in Winston-Salem, North Carolina.
Read More on ProKidney

Today's Range

Now: $2.11
Low: $2.08
High: $2.24

50 Day Range

MA: $2.93
Low: $2.11
High: $4.20

52 Week Range

Now: $2.11
Low: $1.12
High: $13.51


279,771 shs

Average Volume

643,527 shs

Market Capitalization

$483.91 million

P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of ProKidney?

ProKidney's top insider shareholders include:
  1. Control Empresarial De Capital (Insider)
  2. Pablo G Legorreta (Director)
  3. Chamath Palihapitiya (Major Shareholder)
  4. Darin J Weber (SVP)
  5. Darin J Weber (Insider)
Learn More about top insider investors at ProKidney.